Skip to search.
 FTSE 100 Up 3.08%

Abaxis, Inc. (ABAX)

-NasdaqGS
38.77 Up 0.12(0.31%) 12 Feb 21:00
Prev Close:38.65
Open:39.47
Bid:N/A
Ask:65.00 x 800
1y Target Est:55.25
Beta:0.654195
Earnings Date:28 Apr - 2 May (Est.)
Day's Range:38.45 - 39.83
52wk Range:37.71 - 66.89
Volume:300,265
Avg Vol (3m):203,253
Market Cap:877.83m
P/E (ttm):26.04
EPS (ttm):1.49
Div & Yield:0.44 (1.14%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ABAX at this time.

Comparison

Symbol% ChgMkt Cap
ABAXUp 0.31%877.83m
HSKA 0.00%215.24m
IDXXUp 0.86%6.35b
ALRDown 0.13%4.56b

Key Statistics

Forward P/E (1 yr):26.02
P/S (ttm):4.09
Ex-Dividend Date:01-Mar-16

Analysts

Annual EPS Est (Mar-16) :1.32
Quarterly EPS Est (Mar-16) :0.32
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.95

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide blood constituent measurements for clinicians worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback